GNY Renal Roundtable: Early Management of CKD in Type 2 Diabetes Patients
Virtual Event

GNY Renal Roundtable: Early Management of CKD in Type 2 Diabetes Patients

Hosted by NKF Serving Greater New York
Thursday, September 29, 2022 - 6:30pm to 7:30pm
Register for This Event

About This Event

Attend a free virtual Renal Roundtable program focusing on Early Management of CKD in Type 2 Diabetes Patients on September 29, 2022 at 6:30pm EST. This virtual roundtable will feature a moderated discussion of an interdisciplinary panel, including a primary care clinician, endocrinologist, and nephrologist to highlight the disease burden, testing recommendations, available treatments, and new technologies. It also featured engaging case presentations and discussion with the participants. Participation in this event directly supports NKF's goal of advancing programs to improve recognition and management of kidney disease, especially for communities facing health disparities.

 

Why is this topic so important?

It is estimated that over 2.2 million adults in New York state are living with chronic kidney disease (CKD), approximately 1.9 million remain undiagnosed. 

  • Diabetes is the leading cause of CKD and hypertension is second leading cause.[i]
  • Fewer than 40% of people with diabetes are being tested for CKD according to recommended guidelines. For patients with hypertension its less than 10% of people tested.[ii]
  • Many clinicians have the perception that because they are treating diabetes or high blood pressure that they are managing CKD.
    • The majority of people with CKD and diabetes and or do not have their diabetes or hypertension controlled.
    • Underlying, undiagnosed CKD contributes to breakdowns in diabetes management and optimizing diabetes care starts with awareness of CKD and testing for those at greatest risk.
    • With new, game-changing therapies available, it is imperative to get those at-risk tested and appropriated diagnosed.
  • There are significant health disparities across the spectrum of kidney disease with Communities of Color being disproportionately affected by these breakdowns in care.[iii]
  • Social determinants, including economic insecurity, food insecurity and access to care, contribute to the challenges faced by people living with kidney disease.[iv]
For more information about this event contact Monique Hardin-Cordero at monique.hardincordero@kidney.org / 212.889.2210
Event Details

Faculty

Ira S. Meisels, M.D - Moderator
Ira S. Meisels, M.D. graduated Yale School of Medicine in 1990 and completed an Internal Medicine Residency and Nephrology Fellowship at Harvard Medical School, Beth Israel Hospital, Boston. He is Chief of the Division of Nephrology of Mount Sinai Morningside and Mount Sinai West Hospitals, Associate Chair of the Department of Medicine of Mount Sinai Morningside and West, and Professor of Medicine at the Icahn School of Medicine at Mount Sinai. An active clinician and educator, he is Co-Chair of the Medical Advisory Board of the National Kidney Foundation of GNY and a past committee chair of the Renal Physicians Association. Dr. Meisels has published in multiple areas of kidney disease and has been a frequent speaker on kidney disease.
Dr. Aida Vega, MD
Dr. Aida Vega, MD is Associate Professor of Medicine and System Vice Chair for Ambulatory Care, Mount Sinai Health System. She has over 30 years of experience in practicing patient–centered primary care. Her expertise is in ambulatory care redesign that focuses on value-based care, chronic disease management and quality of care. Her clinics consistently achieve and exceed Hedis Quality Measures. During the COVID pandemic, she was instrumental in developing Telehealth initiatives in the Mount Sinai Health System in ambulatory care. She is mentor to many physicians, students and staff in the ambulatory care practice.
David W. Lam, MD
David W. Lam, MD received his medical degree from the University of Maryland School of Medicine and completed his internal medicine residency at Thomas Jefferson University in Philadelphia, PA. and his fellowship in Endocrinology at the Icahn School of Medicine at Mount Sinai. As an Endocrinologist, his clinical focus is in the care of patients living with diabetes. He is also the Medical Director of the Mount Sinai Clinical Diabetes Institute for the Mount Sinai Health System. In this role he champions diabetes related initiatives and care pathways across the Mount Sinai Health System, ensuring and promoting quality health care for those living with diabetes.
Joji Tokita, MD
Joji Tokita, MD is the Clinical Director, Division of Nephrology Associate Professor, Medicine Icahn School of Medicine at Mount Sinai. Specific interests include quality assessment and performance improvement in the context of population health approaches to both CKD and ESRD.Current research is focused on identification of patients with type 2 diabetes who may be at high risk for progression of underlying kidney disease.

Sponsor

Renalytix

[i] U.S. Department of Health and Human Services (HHS); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Causes of chronic kidney disease. NIDDK website. 2016, October. https://www.niddk.nih.gov/health-information/kidney-disease/ chronic-kidney-disease-ckd/causes

[ii] United States Renal Data System. 2016 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016

[iii] Scholle SH, Onstad K, Hart A, Hwee T; National Committee for Quality Assurance (NCQA). Chronic kidney disease disparities: educational guide for primary care. Washington, DC: Department of Health and Human Services (DHHS), Centers for Medicare & Medicaid Services (CMS), Office of Minority Health (OMH); February 2020.

[iv] Crews DC, Kuczmarski MF, Grubbs V, et al. Effect of food insecurity on chronic kidney disease in lower‐income Americans. Am J Nephrol. 2014;39(1):27‐35. 10.1159/000357595

Share

About the NKF

The National Kidney Foundation (NKF) is the largest, most comprehensive and longstanding organization dedicated to the awareness, prevention and treatment of kidney disease.
Register for This Event